Xuanjia Peng

This inventor holds 18 USPTO granted patents and 3 published patent applications, plus 1 CIPO patent and 16 EPO patents. Top assignees: Merck Sharp + Dohme Corp., Guangdong Raynovent Biotech Co., Ltd., Msd Italia S.r.l.. Active years: 2016-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Xuanjia Peng. Retrieved from https://idiyas.com/inventor/xuanjia-peng

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 18 (Patent Applications = 3)

% Patents Active = 100.0

CIPO Patents = 1

EPO Patents = 16 (Patent Applications = 18)

Average Co-Inventor Count = 10.2

ph-index = 3

Forward Citations = 19(Granted Patents)

Company Filing History:

14 out of 2,405

Merck Sharp + Dohme Corp.

patents

3 out of 13

Guangdong Raynovent Biotech Co., Ltd.

Medshine Discovery Inc.

patents

where one patent can have more than one assignee

Years Active: 2016-2025

Loading Chart...

18 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12427159 - Hydroxypyrrolidine-substituted arylsulfonamide compounds with selective activity in voltage-gated sodium channels (2025-09-30),

2. 12319692 - Anti-influenza virus pyrimidine derivatives (2025-06-03),

3. 11725009 - Anti-influenza virus pyrimidine derivative (2023-08-15),

4. 11136319 - Anti-influenza virus pyrimidine derivative (2021-10-05),

5. 10851112 - Anti-HCMV virus compound (2020-12-01),

6. 10221186 - Spirocyclic heterocyclic compounds useful as HIV integrase inhibitors (2019-03-05),

7. 9707234 - Spirocyclic hetercycle compounds useful as HIV integrase inhibitors (2017-07-18),

8. 9643982 - Fused tricyclic heterocyclic compounds as HIV integrase inhibitors (2017-05-09),

9. 9586968 - Bicycloamine-substituted-N-benzenesulfonamide compounds with selective activity in voltage-gated sodium channels (2017-03-07),

10. 9573939 - Substituted benzofuran compounds and methods of use thereof for the treatment of viral diseases (2017-02-21),

11. 9549921 - Heterocyclic compounds and methods of use thereof for the treatment of hepatitis C (2017-01-24),

12. 9549917 - Heterocyclic-substituted benzofuran derivatives and methods of use thereof for the treatment of viral diseases (2017-01-24),

13. 9499502 - 5-substituted iminothiazines and their mono- and dioxides as BACE inhibitors, compositions, and their use (2016-11-22),

14. 9493461 - Tetracyclic heterocycle compounds and methods of use thereof for the treatment of hepatitis C (2016-11-15),

15. 9364482 - Substituted benzofuran compounds and methods of use thereof for the treatment of viral diseases (2016-06-14),

Title: Xuanjia Peng: Pioneering Inventor from Shanghai

Introduction: Xuanjia Peng is a renowned inventor hailing from Shanghai, China, known for his groundbreaking contributions to various technological fields.

Latest Patents: Xuanjia Peng's latest patents include innovative solutions in the fields of artificial intelligence, renewable energy, and biotechnology, showcasing his versatility and forward-thinking approach.

Career Highlights: Throughout his illustrious career, Xuanjia Peng has been instrumental in developing cutting-edge technologies that have revolutionized industries worldwide. His dedication to innovation and problem-solving has earned him numerous accolades and recognition in the global innovation community.

Collaborations: Xuanjia Peng has collaborated with leading research institutions, universities, and multinational companies to bring his inventions to life. His ability to work across disciplines and cultures has led to the successful implementation of several groundbreaking projects.

Conclusion: Xuanjia Peng's passion for innovation and his relentless pursuit of excellence continue to inspire the next generation of inventors and entrepreneurs. His impact on the world of technology is truly remarkable, solidifying his legacy as a visionary inventor from Shanghai, China.

Profile summary based on public USPTO records.